Khosla Khosla

Mr. Khosla Khosla

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Radiology
Verified
Journal Article
Closed access
RDRushabh Doshi
Rushabh Doshi
KAKanhai S. Amin
Kanhai S. Amin
KKKhosla Khosla
Khosla Khosla
SBSimar Bajaj
Simar Bajaj
SCSophie Chheang
Sophie Chheang
HFHOWARD Paul FORMAN
HOWARD Paul FORMAN
Background The complex medical terminology of radiology reports may cause confusion or anxiety for patients, especially given increased access to electronic health records. Large language models (LLMs) can potentially simplify radiology report readability. Purpose To compare the performance of four publicly available LLMs (ChatGPT-3.5 and ChatGPT-4, Bard [now known as Gemini], and Bing) in producing simplified radiology report impressions. Materials and Methods In this retrospective comparative analysis of the four LLMs (accessed July 23 to July 26, 2023), the Medical Information Mart for Intensive Care (MIMIC)-IV database was used to gather 750 anonymized radiology report impressions covering a range of imaging modalities (MRI, CT, US, radiography, mammography) and anatomic regions. Three distinct prompts were employed to assess the LLMs' ability to simplify report impressions. The first prompt (prompt 1) was "Simplify this radiology report." The second prompt (prompt 2) was "I am a patient. Simplify this radiology report." The last prompt (prompt 3) was "Simplify this radiology report at the 7th grade level." Each prompt was followed by the radiology report impression and was queried once. The primary outcome was simplification as assessed by readability score. Readability was assessed using the average of four established readability indexes. The nonparametric Wilcoxon signed-rank test was applied to compare reading grade levels across LLM output. Results All four LLMs simplified radiology report impressions across all prompts tested (P < .001). Within prompts, differences were found between LLMs. Providing the context of being a patient or requesting simplification at the seventh-grade level reduced the reading grade level of output for all models and prompts (except prompt 1 to prompt 2 for ChatGPT-4) (P < .001). Conclusion Although the success of each LLM varied depending on the specific prompt wording, all four models simplified radiology report impressions across all modalities and prompts tested. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Rahsepar in this issue.

1 November 2023 in Radiology
Verified
Journal Article
Closed access
KAKanhai S. Amin
Kanhai S. Amin
MDMelissa A. Davis
Melissa A. Davis
RDRushabh Doshi
Rushabh Doshi
AHAndrew H. Haims
Andrew H. Haims
KKKhosla Khosla
Khosla Khosla
HFHOWARD Paul FORMAN
HOWARD Paul FORMAN

5 June 2023 in medRxiv
Verified
Preprint
Open access
PDF file
RDRushabh Doshi
Rushabh Doshi
KAKanhai Amin
Kanhai Amin
KKKhosla Khosla
Khosla Khosla
SBSimar Bajaj
Simar Bajaj
SCSophie Chheang
Sophie Chheang
HFHOWARD Paul FORMAN
HOWARD Paul FORMAN
This paper investigates the application of Large Language Models (LLMs), specifically OpenAI’s ChatGPT3.5, ChatGPT4.0, Google Bard, and Microsoft Bing, in simplifying radiology reports, thus potentially enhancing patient understanding. We examined 254 anonymized radiology reports from diverse examination types and used three different prompts to guide the LLMs’ simplification processes. The resulting simplified reports were evaluated using four established readability indices. All LLMs significantly simplified the reports, but performance varied based on the prompt used and the specific model. The ChatGPT models performed best when additional context was provided (i.e., specifying user as a patient or requesting simplification at the 7th grade level). Our findings suggest that LLMs can effectively simplify radiology reports, although improvements are needed to ensure accurate clinical representation and optimal readability. These models have the potential to improve patient health literacy, patient-provider communication, and ultimately, health outcomes.

10 November 2023 in medRxiv
Verified
Preprint
Open access
PDF file
HKHarlan M. Krumholz
Harlan M. Krumholz
YWYilun Wu
Yilun Wu
MSMitsuaki Sawano
Mitsuaki Sawano
RSRishi Shah
Rishi Shah
TZTianna Zhou
Tianna Zhou
AIAkiko Iwasaki
Akiko Iwasaki
Introduction: A chronic post-vaccination syndrome (PVS) after covid-19 vaccination has been reported but has yet to be well characterized. Methods: We included 241 individuals aged 18 and older who self-reported PVS after covid-19 vaccination and who joined the online Yale Listen to Immune, Symptom and Treatment Experiences Now (LISTEN) Study from May 2022 to July 2023. We summarized their demographics, health status, symptoms, treatments tried, and overall experience. Results: The median age of participants was 46 years (interquartile range [IQR]: 38 to 56), with 192 (80%) identifying as female, 209 (87%) as non-Hispanic White, and 211 (88%) from the United States. Among these participants with PVS, 127 (55%) had received the BNT162b2 [Pfizer-BioNTech] vaccine, and 86 (37%) received the mRNA-1273 [Moderna] vaccine. The median time from the day of index vaccination to symptom onset was three days (IQR: 1 day to 8 days). The time from vaccination to symptom survey completion was 595 days (IQR: 417 to 661 days). The median Euro-QoL visual analogue scale score was 50 (IQR: 39 to 70). The five most common symptoms were exercise intolerance (71%), excessive fatigue (69%), numbness (63%), brain fog (63%), and neuropathy (63%). In the week before survey completion, participants reported feeling unease (93%), fearfulness (82%), and overwhelmed by worries (81%), as well as feelings of helplessness (80%), anxiety (76%), depression (76%), hopelessness (72%), and worthlessness (49%) at least once. Participants reported a median of 20 (IQR: 13 to 30) interventions to treat their condition. Conclusions: In this study, individuals who reported PVS after covid-19 vaccination had low health status, high symptom burden, and high psychosocial stress despite trying many treatments. There is a need for continued investigation to understand and treat this condition.

15 February 2019 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
VSVishakha Sharma
Vishakha Sharma
KJKrupa Jani
Krupa Jani
KKKhosla Khosla
Khosla Khosla
EBErin Butler
Erin Butler
DSDonald Siegel
Donald Siegel
EWElisa Wurmbach
Elisa Wurmbach

27 October 2022 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
MVMiguel Verbitsky
Miguel Verbitsky
SKSarathbabu Krishnamurthy
Sarathbabu Krishnamurthy
PKPriya Krithivasan
Priya Krithivasan
DHDaniel Hughes
Daniel Hughes
AKAtlas Khan
Atlas Khan
AGAli G. Gharavi
Ali G. Gharavi
Significance Statement: Pathogenic structural genetic variants, also known as genomic disorders, have been associated with pediatric CKD. This study extends those results across the lifespan, with genomic disorders enriched in both pediatric and adult patients compared with controls. In the Chronic Renal Insufficiency Cohort study, genomic disorders were also associated with lower serum Mg, lower educational performance, and a higher risk of death. A phenome-wide association study confirmed the link between kidney disease and genomic disorders in an unbiased way. Systematic detection of genomic disorders can provide a molecular diagnosis and refine prediction of risk and prognosis. Background: Genomic disorders (GDs) are associated with many comorbid outcomes, including CKD. Identification of GDs has diagnostic utility. Methods: We examined the prevalence of GDs among participants in the Chronic Kidney Disease in Children (CKiD) cohort II (n=248), Chronic Renal Insufficiency Cohort (CRIC) study (n=3375), Columbia University CKD Biobank (CU-CKD; n=1986), and the Family Investigation of Nephropathy and Diabetes (FIND; n=1318) compared with 30,746 controls. We also performed a phenome-wide association analysis (PheWAS) of GDs in the electronic MEdical Records and GEnomics (eMERGE; n=11,146) cohort. Results: We found nine out of 248 (3.6%) CKiD II participants carried a GD, replicating prior findings in pediatric CKD. We also identified GDs in 72 out of 6679 (1.1%) adult patients with CKD in the CRIC, CU-CKD, and FIND cohorts, compared with 199 out of 30,746 (0.65%) GDs in controls (OR, 1.7; 95% CI, 1.3 to 2.2). Among adults with CKD, we found recurrent GDs at the 1q21.1, 16p11.2, 17q12, and 22q11.2 loci. The 17q12 GD (diagnostic of renal cyst and diabetes syndrome) was most frequent, present in 1:252 patients with CKD and diabetes. In the PheWAS, dialysis and neuropsychiatric phenotypes were the top associations with GDs. In CRIC participants, GDs were associated with lower serum magnesium, lower educational achievement, and higher mortality risk. Conclusion: Undiagnosed GDs are detected both in children and adults with CKD. Identification of GDs in these patients can enable a precise genetic diagnosis, inform prognosis, and help stratify risk in clinical studies. GDs could also provide a molecular explanation for nephropathy and comorbidities, such as poorer neurocognition for a subset of patients. Podcast: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2023_04_03_JASN2022060725.mp3